2019 BioFlorida Annual Conference

2019 BioFlorida Annual Conference

LGM Pharma, Trade Shows & Events

On October 20-22, 2019, LGM Pharma exhibited at the 2019 BioFlorida Annual Conference in Tampa, FL. We participated in two full days of informative sessions, where we were able to hear from life science executives and connect with hundreds in the life sciences industry.


2:30 PM – 4:00 PM – Chapter Leadership Meeting (Closed Meeting)
3:30 PM – 7:00 PM – Exhibitor Move-In/Setup
3:00 PM – 7:00 PM – On-Site Registration Opens
5:00 PM – 7:00 PM – Welcome Reception

7:30 AM – 6:30 PM – On-Site Registration Opens
7:30 AM – 8:30 AM – Breakfast with Exhibitors
8:30 AM – 6:00 PM – 1:1 Partnering Opens
8:30 AM – 10:00 AM – General Session:
Conference Welcome

  • Nancy K. Bryan, President & CEO, BioFlorida
  • Jane Castor, Mayor, City of Tampa
    Keynote: “How Microbiome Research is Changing Medicine”

  • Christian Brechot, MD, PhD, Senior Associate Dean for Research in Global Affairs, USF Health Morsani College of Medicine; Associate Vice President, International Partnerships and Innovation; Professor, Department of Internal Medicine
    Award Presentations
  • David J. Gury Company of the Year Award (presented by Robert G. Finizio, CEO, Co-Founder and Director, TherapeuticsMD, Inc.)
  • Lifetime Achievement Award
  • 10:00 AM – 10:10 AM – Break with Exhibitors

10:10 AM – 11:40 AM
Breakout Sessions:
BIOSCIENCE: Metabolomics: Evolving Technology Platform for Probing Disease Mechanisms and Discovering Novel Biomarkers

  • Robert Herzog, Vice President of Research Operations, AdventHealth (moderator)
  • Stephen Gardell, PhD, Senior Investigator, AdventHealth Orlando
  • John Koomen, PhD, Associate Member, Moffitt Cancer Center
  • Boone M. Prentice, PhD, Assistant Professor, Department of Chemistry, University of Florida

BIOBUSINESS: Company Showcase: Spotlight on Florida Innovation & Growth

  • Jeffrey L. Tate, PhD, Chief Operating Officer and Chief Quality Officer, Cyclo Therapeutics, Inc. (moderator)
  • Kal Fishman, Chief Technology Officer, Sensus Healthcare, Inc.
  • Adam Grossman, President and CEO, ADMA Biologics, Inc.
  • Patricia Lawman, PhD, CEO, Morphogenesis, Inc.
  • Robert J. Shovlin, President, Clinical Services, NeoGenomics Laboratories, Inc.

11:20 AM – 12:20 PM – Government Affairs Committee Meeting (BioFlorida Members only)
11:40 AM – 12:00 PM – Break with Exhibitors
12:00 PM – 1:40 PM – Lunch
General Session Panels:
Meet New Research Organizations and Companies: Why Choose Florida

  • Karen Moore, Founder and CEO, Moore, Inc. (moderator)
  • Joseph P. Iannotti MD, PhD, Chief of Staff and Chief Academic and Innovation Officer, Cleveland Clinic Florida
  • Richard E. Pietroski, President, Lung Bioengineering, Inc.
  • Ulf Wiinberg, President and CEO, X-Vax Technology, Inc.
    Grow Florida – Economic Development Strategies to Expand the Industry
  • Valerie McDevitt, Senior Director, Research Services, AdventHealth (moderator)
  • Douglas A. Bingham, Executive Vice President, Florida Operations, Scripps Research
  • Lee H. Evans, Executive Director, Head of North America Capability Center and Global Strategic Operations, Bristol-Myers Squibb
  • Norma Sue Kenyon, PhD, Chief Innovation Officer, University of Miami
  • Jim O’Connell, Assistant Vice President for Commercialization,     University of Florida
  • Juan Carlos Varela, Vice President, Restorative Therapies Group Latin America, Medtronic

1:40 PM – 1:50 PM – Break with Exhibitors
1:50 PM – 3:15 PM
Breakout Sessions:
BIOSCIENCE: Stopping Cancer in Its Tracks: Making Treatment Personal

  • Douglas W. Calder, President, Vycellix, Inc. (moderator)
  • Bob Crutchfield, Managing Director, American Cancer Society / BrightEdge
  • Matthew H.J. Kim, JD, Co-Founder and Chairman, STAT3 Therapeutics, Inc.
  • Shari Pilon-Thomas, PhD, Associate Member, Moffitt Cancer Center
  • Michelle Simpson-Abelson, PhD, Senior Scientist/Project Team Lead, Iovance Biotherapeutics
  • Hing Wong, PhD, Founder and CEO, HCW Biologics
    BIOTRENDS: Expanding Role of Robotics & Simulation
  • Sean Hägen, Founder and Principal, BlackHägen Design (moderator)
  • Eric Branch, Sr Marketing Manager, Robotics Portfolio Strategy, Stryker
  • Danielle Julian, Senior Research Scientist, AdventHealth Nicholson Center
  • Matthew Lee, Simulation Engineer, Center for Medical Simulation and Innovative Education, Johns Hopkin’s All Children’s Hospital
  • Phillip Wortham, Director of Operations, USF Health CAMLS
    BIOBUSINESS: Changing Dynamics for Successful Commercialization
  • Gina Alexis, Co-Founder and President, The Alexis Group Consultants, Inc. (moderator)
    • Anton Hopen, Managing Partner, Smith & Hopen
  • Drew Pantello, VP, Marketing and Corporate Development, ADMA Biologics, Inc.
  • Karl Pinto, CEO, Goodwin Biotechnology, Inc.
  • Michael L. Salgaller, PhD, Supervisor, Invention Development and Marketing Unit, National Institutes of Health

3:15 PM – 5:00 PM – BioPitch Closed-Door Sessions
3:15 PM – 3:35 PM – Break with Exhibitors
3:35 PM – 4:50 PM
Breakout Sessions:
BIOSCIENCE: Florida’s Opioid Crisis and Plans for Prevention

  • Stacey S. DeLoye, Director of Communications, Scripps Research (moderator)
  • Laura M. Bohn, PhD, Professor, Department of Molecular Medicine, Scripps Research
  • Ute Gazioch, Director of Substance Abuse and Mental Health, Department of Children and Families
  • Stephanie Nelson Wimmer, Vice President, Reimbursement and Health Economics, Pain Therapies and Brain Therapies, Medtronic
  • Mark O’Brien, CEO, Springlake Solutions
  • David Samuels, MD, TeamHealth Anesthesiologist, Tampa General Hospital; Founder, NOPE! (Non-Opioid Perioperative Engagement)
    BIOTRENDS: Conversations with Women Leaders
  • Patti Rossman, Co-Founder, Life Science Women’s Conference (moderator)
  • Julia M. Amadio, Chief Product Officer, TherapeuticsMD, Inc.
  • Tamara Mandell, Director, Biotility, University of Florida
  • Jonelle L. Toothman, Co-Founder and CEO, NeXtGen Biologics, Inc.
  • Sigrid M. Volko, PhD, President and CEO, Nilogen Oncosystems
    BIOBUSINESS: Next Generation Technology: MedTech & HealthIT
  • Habeel Gazi, Life Sciences Senior Director, Business Development, Orlando Economic Partnership (moderator)
  • Matthew R. Benson, MD, Pediatric Endocrinologist, Nemours Children’s Health System
  • Nicole Ferrari, Director of Engineering, Bausch & Lomb
  • Maha Sallam, PhD, Founder & President, VuEssence Inc.
  • Brandi Zofkie, General Manager and Ex Vivo Lung Specialist, Lung Bioengineering Inc.

4:50 PM – 5:00 PM – Break with Exhibitors
5:00 PM – 6:00 PM
CEO Forum

  • Weaver H. Gaines, Co-Founder, Chairman and CEO, Evren Technologies, Inc. (moderator)
    Research Forum
  • Robert Herzog, Vice President of Research Operations, AdventHealth (moderator)
  • Gary S. Margules, Sc.D., Vice President for Office of Research and Technology Transfer, Nova Southeastern University (moderator)
    Incubator / Accelerator Forum
  • Mark S. Long, Director, Incubation Services, UF Innovate (moderator)

6:30 PM – 8:00 PM – Evening Reception

7:30 AM – 2:00 PM – On-Site Registration Opens
7:30 AM – 8:15 AM – MedTech Committee
8:00 AM – 2:00 PM – 1:1 Partnering Opens
7:30 AM – 8:30 AM– Breakfast with Exhibitors
8:30 AM – 9:15 AM
General Session:
Award Presentations

  • Weaver H. Gaines Entrepreneur of the Year Award (presented by Weaver H. Gaines, Co-Founder, Chairman and CEO, Evren Technologies, Inc.)
  • BioFlorida Leadership Award
    Keynote: A Personal Story: How Industry Improves Lives
  • Jenesis Rothblatt, Project Leader, Corporate Telepresence & Robotics, United Therapeutics Corporation

9:15 AM – 9:20 AM – Transition Break
9:20 AM – 10:35 AM
Breakout Sessions:
BIOSCIENCE: Accelerating Regenerative Medicine in Florida: Challenges and Opportunities Ahead

  • Ezequiel Zylberberg, PhD, Manager, Strategic Alliances, Akron Biotech (moderator)
  • Charles J. Bruce, MD, Chief Innovation Officer and Medical Director, Life Sciences Incubator, Mayo Clinic Florida
  • Geoff Green, President, Longeveron
  • Keith March, MD, PhD, Professor of Medicine, UF Division of Cardiology and Director, UF Center for Regenerative Medicine
  • David Shepard, Director, Orthobiologics, Arthrex, Inc.
    BIOTRENDS: “Building” to Expand
  • Jim Rizzi, Head of Facilities, Max Planck Florida Institute for Neuroscience (moderator)
  • R. Scott Crawford, Science Studio Leader, RS&H, Inc.
  • J. Lee Emel, Southeast Regional Leader, CRB
  • Douglas M. Ruth, Jr., Vice President, The Whiting-Turner Contracting Company
  • Nathan Temple, Global Director of CQV Services, Commissioning Agents, Inc.
    BIOBUSINESS: Investor Discussion: What Executives Need to Know
  • Quang Pham, Founder, Chairman and CEO, Espero BioPharma, Inc. (moderator)
  • Ibraheem T. Badejo, PhD, Sr. Director, New Ventures, Medical Devices, Johnson & Johnson Innovation
  • Charles (Chip) Steiner, Director, Business & Product Development, Innovations, Cleveland Clinic
  • Ryan Whittemore, Chief Investment Officer, Florida Funders
  • Rhys Williams, Chairman and Co-Founder, New World Angels

10:35 AM – 10:50 AM
Break with Exhibitors
10:50 AM – 1:00 PM
General Session:
BioPitch Finals

  • Jane E. Teague, Executive Director, Institute for Commercialization of Florida Technology (moderator)
  • Tim Cartwright, Chairman, Tamiami Angel Funds
  • Kathy Chiu, Managing Partner, DeepWork Capital
  • Shawn Titcomb, Managing Director, Allele Capital Partners
  • Harry Venezia, Jr., Managing Director, Healthcare Capital Advisors
    CEO Panel: Keys to Success
  • Julie Kampf, CEO and Chief Possibilities Officer, JBK Associates International, Inc. (moderator)
  • Stephen Glover, Co-Founder, CEO and President, ZyVersa Therapeutics
  • Adam Grossman, President and CEO, ADMA Biologics, Inc.
  • Peter J. Mariani, CFO, Axogen
    BioPitch Winner is Announced!
    Closing Remarks
  • Nancy K. Bryan, President & CEO, BioFlorida

1:00 PM – Grab-and-Go Lunch
1:30 PM – 3:00 PM – BioFlorida Board Meeting (Closed Meeting)

About BioFlorida

BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.

Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.



  • Share:

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service